You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 2, July 10, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •World Health
 •Immunology
 •Immunologic Disorders
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Unequal Epidemic in an Unequal World

Kevin M. De Cock, MD,FRCP,DTM&H; Robert S. Janssen, MD

JAMA. 2002;288:236-238.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In July 2002, approximately 15 000 clinicians, researchers, and other interested persons will gather once again, this time at the XIV International AIDS Conference in Barcelona, to discuss what is arguably the worst plague the world has ever known. These international conferences and their venues are milestones in the history of this tragic epidemic. In 1985, Atlanta hosted the first meeting; in 1996, the Vancouver meeting introduced combination therapy and viral load testing to the world; and in 2000, Durban drew international attention to Africa's plight. Barcelona offers further opportunity for dialogue, reflection on epidemiology and response, and strengthening global resolve.

The United States is the most heavily affected country in the industrialized world with almost 1 million persons living with HIV (human immunodeficiency virus).1 Important successes have included the prevention of HIV/AIDS (acquired immunodeficiency syndrome) transmitted through blood and blood products; . . . [Full Text of this Article]

Author Affiliations: CDC-Kenya, Nairobi, Kenya (Dr De Cock), and Division of HIV/AIDS Prevention—Surveillance and Epidemiology, National Center for HIV, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Janssen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human Immunodeficiency Virus: Anesthetic and Obstetric Considerations
Evron et al.
Anesth. Analg. 2004;98:503-511.
ABSTRACT | FULL TEXT  

Understanding the Threat of HIV/AIDS
Luo
JAMA 2002;288:1649-1649.
FULL TEXT  

International Health: Purpose, Value, Challenges
Modjarrad
JAMA 2002;288:1648-1648.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.